Plandaí Biotechnology, Inc. (PLPL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 411.98 Thousand |
| Cost of Revenue | - | - | - | - | - | 2.22 Million |
| Gross Profit | - | - | - | - | - | -1.81 Million |
| Operating Expenses | 3.81 Million | 705.5 Thousand | 24.27 Thousand | 105 Thousand | - | 1.26 Million |
| Selling, General and Administrative Expenses | 3.81 Million | 705.5 Thousand | 24.27 Thousand | 105 Thousand | - | 1.25 Million |
| Research and Development Expenses | - | - | - | - | - | 4025.00 |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.81 Million | 705.5 Thousand | 24.27 Thousand | 105 Thousand | - | 3.48 Million |
| Operating Income | -3.81 Million | -705.5 Thousand | -24.27 Thousand | -105 Thousand | - | -3.07 Million |
| Interest Expense | 4530.03 | 28.2 Thousand | 116.71 Thousand | 111.85 Thousand | 83.48 Thousand | 2.07 Million |
| Income Tax Expense | 16.02 Million | -200.28 Thousand | -119.83 Thousand | -206.29 Thousand | - | -590.38 Thousand |
| Earnings before Tax | 16.02 Million | -19.8 Million | 6.82 Million | -396.75 Thousand | -83.48 Thousand | -4.59 Million |
| Net Income | 16.02 Million | -19.8 Million | 6.82 Million | -396.75 Thousand | -83.48 Thousand | -4 Million |
| Earnings Per Share Basic | 0.00 | -0.00 | 0.00 | -0.00 | - | -0.02 |
| Earnings Per Share Diluted | 0.00 | -0.00 | 0.00 | -0.00 | - | -0.02 |
| Weighted Average Shares Outstanding | 44.88 Billion | 7.54 Billion | 6.36 Billion | 2.61 Billion | 3.04 Billion | 262.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.88 Billion | 7.56 Billion | 7.05 Billion | 2.61 Billion | 3.04 Billion | 262.9 Million |
| Gross Margin | - | - | - | - | - | -4.40 |
| EBIT Margin | - | - | - | - | - | -6.17 |
| Profit Margin | - | - | - | - | - | -9.73 |
| EBITDA | 16.03 Million | -19.77 Million | 6.94 Million | -105 Thousand | 171.86 Thousand | -1.99 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -7.47 |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 3.8 Million | 217.23 Thousand | 100.00 | 3960.00 | 705.5 Thousand | 681.69 Thousand |
| Selling, General and Administrative Expenses | 3.8 Million | - | 100.00 | 3960.00 | - | 681.69 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 217.23 Thousand | - | - | - | - |
| Cost and Expenses | 3.8 Million | 217.23 Thousand | 100.00 | 3960.00 | 705.5 Thousand | 681.69 Thousand |
| Operating Income | -3.8 Million | 217.23 Thousand | -100.00 | -3960.00 | -705.5 Thousand | -681.7 Thousand |
| Interest Expense | - | 197.51 | 2166.00 | 2166.00 | 28.2 Thousand | 3029.00 |
| Income Tax Expense | -1.00 | - | -122.08 Thousand | -41.58 Thousand | -200.28 Thousand | -54.88 Thousand |
| Earnings before Tax | -3.59 Million | 217.03 Thousand | -209.55 Thousand | 19.61 Million | -19.8 Million | -20.08 Million |
| Net Income | -3.59 Million | 217.03 Thousand | -209.55 Thousand | 19.61 Million | -19.8 Million | -20.08 Million |
| Earnings Per Share Basic | -0.00 | - | - | 0.00 | - | -0.00 |
| Earnings Per Share Diluted | -0.00 | - | - | 0.00 | - | -0.00 |
| Weighted Average Shares Outstanding | 44.88 Billion | 8.88 Billion | 8.43 Billion | 8.19 Billion | 7.54 Billion | 8.19 Billion |
| Weighted Average Shares Outstanding (Diluted) | 44.88 Billion | 8.88 Billion | 8.48 Billion | 8.25 Billion | 7.56 Billion | 8.19 Billion |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -3.59 Million | 217.23 Thousand | -100.00 | -3960.00 | - | -681.7 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
KIRLOSIND
DOM
0456
009270
VIDA
THVB